ADMINISTRATION

行政

基本信息

项目摘要

PROJECT SUMMARY (See instructions): The Cancer Institute Administrative Office (AO) plays a crucial role in providing resources and efficient and effective administrative expertise to support the complex and expanding cancer basic and clinical research enterprise across the NYU Langone Medical Center. This includes administrative support to the Office of the Director, Associate Directors, Shared Resource Directors, Program Leaders, and NYUCI membership, as well as the investigators at the Cancer Research Center and the faculty in the Division of Hematology and Medical Oncology. The overarching goal for administration is to facilitate research and provide the infrastructure to move discoveries into the clinical setting. This is done through strategic planning and evaluation initiatives, business and financial planning for research programs and shared resources, development of policies and procedures for prudent financial and grants management for investigators at the Cancer Research Center and Division of Hematology and Medical Oncology, staffing of program meetings, scientific retreats, and seminars, supporting the submission of administratively demanding complex grants such as SPORE's and training grants, human resources, budget and finance, space, informatics, and facilities planning. The administrative team is responsible for all interactions across the NYU Langone Medical Center corporate offices (Grants Finance, Finance, IRB, Office of Clinical Trials, Office of Collaborative Sciences, Sponsored Programs Administration, Medical Center IT, and the Office of Communications). The AO provides services beyond the activities related to the CCSG such as fiscal management of clinical activities, auditing and oversight of clinical research billing compliance, the integration of clinical research operations throughout all clinical sites at the Cancer Institute, and academic and administrative oversight of the Division of Hematology and Medical Oncology and the Cancer Research Laboratories. The core mission of the CCSG defines and dictates the structure and decision-making processes within the administrative unit. There are eight major areas of focus for research administration: central CCSG administration, grants management, membership, shared resources, structure for inter- and intra-disciplinary collaborations, research program support, informatics, and financial management of the Cancer Institute. Support is requested for only those activities directly related to the CCSG.
项目摘要(见说明):癌症研究所行政办公室(AO)在提供资源以及高效和有效的管理专业知识方面发挥着关键作用,以支持整个纽约大学朗格内医学中心复杂和不断扩大的癌症基础和临床研究事业。这包括对主任办公室、副主任、共享资源主任、项目领导人和NYUCI成员的行政支持,以及癌症研究中心的研究人员和血液和内科肿瘤科的教职员工。管理的首要目标是促进研究,并提供基础设施,将发现转移到临床环境中。这是通过战略规划和评估计划、研究计划和共享资源的业务和财务规划、为癌症研究中心和血液与医学肿瘤科的研究人员制定审慎财务和赠款管理的政策和程序、项目会议、科学务虚会和研讨会的人员配备、支持提交行政要求高的复杂赠款(如孢子和培训补助金、人力资源、预算和财务、空间、信息学和设施规划)来实现的。管理团队负责纽约大学朗格尼医学中心公司办公室(赠款财务、财务、IRB、临床试验办公室、协作科学办公室、赞助项目管理、医疗中心IT和通信办公室)的所有互动。 除与CCSG相关的活动外,行政主任还提供与CCSG相关的服务,如临床活动的财务管理、临床研究账单合规的审计和监督、癌症研究所所有临床站点的临床研究业务整合,以及对血液和内科肿瘤科以及癌症研究实验室的学术和行政监督。协调小组的核心任务界定并规定了行政单位内部的结构和决策程序。研究管理有八个主要的重点领域:中央CCSG管理、拨款管理、成员资格、共享资源、学科间和学科内合作的结构、研究计划支持、信息学和癌症研究所的财务管理。只要求对与协调小组直接相关的活动提供支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William L. Carroll其他文献

Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932
低危 B-ALL 儿童采用两种低强度方案的显著结果:来自 COG AALL0932 的报告
  • DOI:
    10.1038/s41375-023-01870-8
  • 发表时间:
    2023-03-25
  • 期刊:
  • 影响因子:
    13.400
  • 作者:
    Reuven J. Schore;Anne L. Angiolillo;John A. Kairalla;Meenakshi Devidas;Karen R. Rabin;Patrick Zweidler-McKay;Michael J. Borowitz;Brent Wood;Andrew J. Carroll;Nyla A. Heerema;Mary V. Relling;Johann Hitzler;Nina S. Kadan-Lottick;Kelly Maloney;Cindy Wang;William L. Carroll;Naomi J. Winick;Elizabeth A. Raetz;Mignon L. Loh;Stephen P. Hunger
  • 通讯作者:
    Stephen P. Hunger
emSubtype Dependent Drug Resistance Alterations in Relapsed Childhood B-ALL: A Children's Oncology Group Study/em
  • DOI:
    10.1182/blood-2022-166489
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Xiaotu Ma;Lingyun Ji;Yanling Liu;Ying Shao;Heather Mulder;Pandurang Kolekar;Quang Tran;Jinghui Zhang;John Easton;William L. Carroll;Patrick A. Brown;Mignon L. Loh
  • 通讯作者:
    Mignon L. Loh
A emD e Novo/em Supernumerary Ring Chromosome 1 Causes B-Cell Acute Lymphoblastic Leukemia in Monozygotic Twins Due to Independent and Partially Convergent Evolutionary Trajectories
一个全新的超数环状染色体 1 由于独立且部分趋同的进化轨迹导致同卵双胞胎患 B 细胞急性淋巴细胞白血病
  • DOI:
    10.1182/blood-2023-181194
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Jesús Gutiérrez-Abril;Gunes Gundem;Elise Fiala;Konstantinos Liosis;Noushin Farnoud;Daniel Leongamornlert;Anu Amallraja;Juan E. Arango Ossa;Dylan Domenico;Max F. Levine;Juan Santiago Medina Martinez;Michael F. Walsh;Sylwia Jasinski;Andrew L. Kung;Neerav N. Shukla;William L. Carroll;Elli Papaemmanuil
  • 通讯作者:
    Elli Papaemmanuil
The Role of over-Expressed β <em>Globin</em> in Driving Relapsed B - Cell Acute Lymphoblastic Leukemia (B-ALL)
  • DOI:
    10.1182/blood-2023-180976
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jessica Krugman;Sylwia Jasinski;Elizabeth A. Raetz;Nikki Evensen;William L. Carroll
  • 通讯作者:
    William L. Carroll
The Role of over-Expressed β emGlobin/em in Driving Relapsed B - Cell Acute Lymphoblastic Leukemia (B-ALL)
过表达的β珠蛋白在驱动复发性 B 细胞急性淋巴细胞白血病(B-ALL)中的作用
  • DOI:
    10.1182/blood-2023-180976
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Jessica Krugman;Sylwia Jasinski;Elizabeth A. Raetz;Nikki Evensen;William L. Carroll
  • 通讯作者:
    William L. Carroll

William L. Carroll的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William L. Carroll', 18)}}的其他基金

Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10381569
  • 财政年份:
    2021
  • 资助金额:
    $ 7.18万
  • 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10184002
  • 财政年份:
    2021
  • 资助金额:
    $ 7.18万
  • 项目类别:
Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome
B细胞急性白血病3D染色质重塑及其对临床结果的影响
  • 批准号:
    10631888
  • 财政年份:
    2021
  • 资助金额:
    $ 7.18万
  • 项目类别:
PROTEOMICS
蛋白质组学
  • 批准号:
    8436447
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
BIOMEDICAL INFORMATICS
生物医学信息学
  • 批准号:
    8436451
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
DEVELOPMENTAL FUNDS
发展基金
  • 批准号:
    8436459
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
EPIDEMIOLOGY AND CANCER CONTROL
流行病学和癌症控制
  • 批准号:
    8436432
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
FLOW CYTOMETRY AND CELL SORTING
流式细胞术和细胞分选
  • 批准号:
    8436444
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
DATA AND SAFETY MONITORING
数据和安全监控
  • 批准号:
    8436456
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:
BIOREPOSITORY CENTER
生物样本库中心
  • 批准号:
    8436441
  • 财政年份:
    2013
  • 资助金额:
    $ 7.18万
  • 项目类别:

相似海外基金

Basic Cancer Research in Cancer Health Disparities
癌症健康差异的基础癌症研究
  • 批准号:
    8725605
  • 财政年份:
    2012
  • 资助金额:
    $ 7.18万
  • 项目类别:
Basic Cancer Research in Cancer Health Disparities
癌症健康差异的基础癌症研究
  • 批准号:
    9136772
  • 财政年份:
    2012
  • 资助金额:
    $ 7.18万
  • 项目类别:
Basic Cancer Research in Cancer Health Disparities
癌症健康差异的基础癌症研究
  • 批准号:
    8389026
  • 财政年份:
    2012
  • 资助金额:
    $ 7.18万
  • 项目类别:
Basic Cancer Research in Cancer Health Disparities
癌症健康差异的基础癌症研究
  • 批准号:
    8547797
  • 财政年份:
    2012
  • 资助金额:
    $ 7.18万
  • 项目类别:
10th Annual McGill Biomedical Conference: Advances in Basic Cancer Research
第十届麦吉尔生物医学年会:基础癌症研究进展
  • 批准号:
    193204
  • 财政年份:
    2009
  • 资助金额:
    $ 7.18万
  • 项目类别:
    Miscellaneous Programs
Consolidated Basic Cancer Research Program
综合基础癌症研究计划
  • 批准号:
    8625567
  • 财政年份:
    1997
  • 资助金额:
    $ 7.18万
  • 项目类别:
Consolidated Basic Cancer Research Program
综合基础癌症研究计划
  • 批准号:
    8894146
  • 财政年份:
    1997
  • 资助金额:
    $ 7.18万
  • 项目类别:
Consolidated Basic Cancer Research Program
综合基础癌症研究计划
  • 批准号:
    8666280
  • 财政年份:
    1997
  • 资助金额:
    $ 7.18万
  • 项目类别:
Consolidated Basic Cancer Research Program
综合基础癌症研究计划
  • 批准号:
    10570928
  • 财政年份:
    1997
  • 资助金额:
    $ 7.18万
  • 项目类别:
Consolidated Basic Cancer Research Program
综合基础癌症研究计划
  • 批准号:
    10244063
  • 财政年份:
    1997
  • 资助金额:
    $ 7.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了